FDA Inspection 1325378 — Shady Grove Reproductive Science Center PC
The FDA completed an inspection of Shady Grove Reproductive Science Center PC on Jun 30, 2026 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 30, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Washington, DC (United States)